Next Article in Journal
Trends and Disparities in Self-Reported and Measured Osteoporosis among US Adults, 2007–2014
Next Article in Special Issue
Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial
Previous Article in Journal
A Nomogram to Predict the Outcome of Fine Needle Aspiration Cytology in Head and Neck Masses
Previous Article in Special Issue
Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
JCM
Volume 8
Issue 12
10.3390/jcm8122051
jcm-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement thumb_up
...
textsms
...
Open AccessReview

Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications

by
Armita Mahdavi Gorabi
1,†,
Nasim Kiaie
1,†,
Saeideh Hajighasemi
2,
Maciej Banach
3,4,
Peter E. Penson
5,
Tannaz Jamialahmadi
6,7 and
Amirhossein Sahebkar
8,9,10,*
1
Research Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran 1411713138, Iran
2
Department of Medical Biotechnology, Faculty of Paramedicine, Qazvin University of Medical Sciences, Qazvin 1531534199, Iran
3
Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 93-338 Lodz, Poland
4
Polish Mother’s Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland
5
School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK
6
Halal Research Center of IRI, FDA, Tehran 1411713138, Iran
7
Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
8
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
9
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
10
School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran
*
Author to whom correspondence should be addressed.
†
The authors contributed equally as the first author.
J. Clin. Med. 2019, 8(12), 2051; https://doi.org/10.3390/jcm8122051
Received: 21 October 2019 / Revised: 16 November 2019 / Accepted: 20 November 2019 / Published: 22 November 2019
(This article belongs to the Special Issue Current and Emerging Uses of Statins in Clinical Therapeutics)
View Full-Text Download PDF
Browse Figures

Abstract

In addition to their cholesterol-lowering effects, statins are associated with pleiotropic effects including improvements in heart failure (HF), reduced blood pressure, prevention of the rupture of atherosclerotic plaques and improved angiogenesis. In addition to these cardiovascular benefits, statins have been implicated in the treatment of neurological injuries, cancer, sepsis, and cirrhosis. These cholesterol-independent beneficial effects of statins are predominantly mediated through signaling pathways leading to increased production and bioavailability of nitric oxide (NO). In this review, the mechanistic pathways and therapeutic effects of statin-mediated elevations of NO are described and discussed. View Full-Text
Keywords: statin; endothelial nitric oxide; angiogenesis; heart failure; atherosclerosis; cancer; neuroprotection statin; endothelial nitric oxide; angiogenesis; heart failure; atherosclerosis; cancer; neuroprotection
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
SciFeed

Share and Cite

MDPI and ACS Style

Gorabi, A.M.; Kiaie, N.; Hajighasemi, S.; Banach, M.; Penson, P.E.; Jamialahmadi, T.; Sahebkar, A. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications. J. Clin. Med. 2019, 8, 2051. https://doi.org/10.3390/jcm8122051

AMA Style

Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, Sahebkar A. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications. Journal of Clinical Medicine. 2019; 8(12):2051. https://doi.org/10.3390/jcm8122051

Chicago/Turabian Style

Gorabi, Armita M.; Kiaie, Nasim; Hajighasemi, Saeideh; Banach, Maciej; Penson, Peter E.; Jamialahmadi, Tannaz; Sahebkar, Amirhossein. 2019. "Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications" J. Clin. Med. 8, no. 12: 2051. https://doi.org/10.3390/jcm8122051

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop